Additionally, Ma et al. (2024) found that ENO1 confers GEM resistance in pancreatic cancer through the Hippo signaling pathway by elevating YAP1 expression, suggesting that the moonlighting function of ENO1 similarly influences cancer chemoresistance. Here, ENO1 is linked to pancreatic neoplasm.